Brand name: Retin-A
Retin-A is a medicine containing the active ingredient(s) tretinoin. On this page you will find out more about Retin-A, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: tretinoin
No information has been found for the selected product. Contact your pharmacist, healthcare professional, or phone healthdirect on 1800 022 222 if you require further help.
Need more information?
These trusted information partners have more on this topic.
Found 325 results
Retinitis pigmentosa
The retina is located at the back of the eye. This thin layer of light-sensitive cells sends information on shape, colour, pattern and movement to the brain via the optic nerve. There are special light sensing cells in the retina, called rods and cones (see explanation below).
Read more on Better Health Channel website
Retinal detachment - detached retina
Retinal detachment (detached retina) is a medical emergency when the retina becomes separated from the inside of the eye. Warning signs include a sudden increase in floaters or flashes. Seek immediate medical attention. This could save your sight.
Read more on myDr website
What is an eye test? | Vision Initiative
Information on the tests included in an eye test
Read more on Vision Initiative website
Eye Health | Common Eye Conditions | Glossary of Eye Conditions
A glossary of eye conditions including information on cataract, diabetic retinopathy, as well as definitions of myopia, hyperopia, and glaucoma. Read more.
Read more on Fred Hollows Foundation website
Glaucoma detection
How is glaucoma detected
Read more on Glaucoma Australia website
Retinopathy in diabetes - myDr.com.au
Diabetic retinopathy occurs when the small blood vessels in the retina become swollen or new tiny blood vessels grow, which damage the retina.
Read more on myDr website
The Eye and Vision | myVMC
The eye enables sight. The eyeball including the lens, retina and pupil which is supported by the optic nerve, eye socket, lids, lashes and muscles.
Read more on myVMC – Virtual Medical Centre website
Learn more about common eye conditions
Understanding the most common types of vision loss This section provides information about the most common eye conditions that cause blindness and low vision
Read more on Vision Australia website
Types of Glaucoma
The term Glaucoma refers to a characteristic pattern of damage to the optic nerve which currently cannot be reversed. For all types of glaucoma, early detection and prompt effective treatment is vital to reduce visual damage.
Read more on Glaucoma Australia website
Diabetes and your eyes
People with diabetes have an increased risk of developing eye complications which, if left untreated, can lead to poor vision and blindness.
Read more on WA Health website
Found 193 results
Interventions for asymptomatic retinal breaks and lattice degeneration for preventing retinal detachment | Cochrane
Interventions for asymptomatic retinal breaks and lattice degeneration for preventing retinal detachment
Read more on Cochrane (Australasian Centre) website
Interventions for prevention of giant retinal tear in the fellow eye | Cochrane
A giant retinal tear is a full-thickness retinal break that extends for 90 degrees or more around the circumference of the retina, in the presence of posterior vitreous detachment (when the vitreous comes away from the retina). Giant retinal tears cause visual loss as a result of the associated retinal detachment. They can be difficult to treat due to the large area of retinal involvement and the high risk of re-detachment following vitreoretinal surgery, often related to the development of proliferative vitreoretinopathy (a scarring process that can happen on the inner or outer surface of the retina and in the vitreous cavity after retinal detachment). As the fellow eye has an increased risk of developing giant retinal tear and retinal detachment, prophylactic 360-degree treatments with laser photocoagulation, cryotherapy or encircling scleral buckling have been proposed to reduce this risk. This review did not find any strong evidence in the form of prospective randomised controlled trials or case-control studies to support or refute these prophylactic treatments.
Read more on Cochrane (Australasian Centre) website
Surgical interventions for rhegmatogenous retinal detachment | Cochrane
In this review we aimed to determine whether pneumatic retinopexy or scleral buckle is a better surgical treatment for rhegmatogenous retinal detachment (RRD).
Read more on Cochrane (Australasian Centre) website
Use of vitamin A and fish oils for retinitis pigmentosa | Cochrane
We investigated how well vitamin A and fish oils work in delaying the progression of visual loss in people with retinitis pigmentosa (RP), and whether these treatments are safe.
Read more on Cochrane (Australasian Centre) website
Intravitreal low molecular weight heparin and 5-Fluorouracil for the prevention of proliferative vitreoretinopathy after retinal reattachment surgery | Cochrane
Intravitreal low molecular weight heparin and 5-Fluorouracil for the prevention of proliferative vitreoretinopathy after retinal reattachment surgery
Read more on Cochrane (Australasian Centre) website
Steroids inserted into the eye versus observation for macular edema secondary to central retinal vein occlusion | Cochrane
Steroids inserted into the eye versus observation for macular edema secondary to central retinal vein occlusion
Read more on Cochrane (Australasian Centre) website
Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion | Cochrane
Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion
Read more on Cochrane (Australasian Centre) website
Treatments for acute central retinal artery occlusion (blockage of the blood supply to the retina of the eye) | Cochrane
Treatments for acute central retinal artery occlusion (blockage of the blood supply to the retina of the eye)
Read more on Cochrane (Australasian Centre) website
Tamponade in surgery for retinal detachment associated with proliferative vitreoretinopathy | Cochrane
We reviewed the effect of tamponade agents used in surgery involving pars plana vitrectomy in participants with retinal detachment (RD) associated with proliferative vitreoretinopathy (PVR).
Read more on Cochrane (Australasian Centre) website
Optical coherence tomography measurement of central retinal thickness to diagnose diabetic macular oedema | Cochrane
Optical coherence tomography measurement of central retinal thickness to diagnose diabetic macular oedema
Read more on Cochrane (Australasian Centre) website
